EdgarLookup

Global Net Lease, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Global Net Lease, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
9.5%
Profit Margin
Net income ÷ revenue
1.1%
Return on Assets
Net income ÷ assets
1.61x
Debt-to-Equity
Total liabilities ÷ equity
-13.1%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $495.29M Feb 25, 2026
FY2025 Dec 31, 2024 $569.79M Feb 25, 2026
FY2025 Dec 31, 2023 $445.76M Feb 25, 2026
FY2024 Dec 31, 2022 $378.86M Feb 27, 2025
FY2023 Dec 31, 2021 $391.23M Feb 27, 2024
FY2020 Dec 31, 2020 $87.04M Feb 26, 2021
FY2020 Sep 30, 2020 $82.71M Feb 26, 2021
FY2020 Jun 30, 2020 $81.11M Feb 26, 2021
FY2020 Mar 31, 2020 $79.24M Feb 26, 2021
FY2020 Dec 31, 2019 $76.69M Feb 26, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2016 Dec 31, 2016 $47.14M Feb 28, 2017
FY2016 Dec 31, 2015 ($2.07M) Feb 28, 2017
FY2015 Dec 31, 2014 ($5.21M) Feb 29, 2016
FY2015 Sep 30, 2014 ($24.56M) Feb 29, 2016
FY2015 Jun 30, 2014 ($7.48M) Feb 29, 2016
FY2015 Mar 31, 2014 ($16.35M) Feb 29, 2016
FY2014 Dec 31, 2013 ($2.60M) Apr 3, 2015
FY2014 Sep 30, 2013 ($3.09M) Apr 3, 2015
FY2014 Jun 30, 2013 ($1.29M) Apr 3, 2015
FY2014 Mar 31, 2013 ($2.0K) Apr 3, 2015

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $110.98M Feb 25, 2026
FY2025 Dec 31, 2024 $188.12M Feb 25, 2026
FY2025 Dec 31, 2023 ($15.29M) Feb 25, 2026
FY2024 Dec 31, 2022 $100.54M Feb 27, 2025
FY2023 Dec 31, 2021 $111.91M Feb 27, 2024
FY2022 Dec 31, 2020 $99.24M Feb 23, 2023
FY2021 Dec 31, 2019 $114.90M Feb 24, 2022
FY2020 Dec 31, 2018 $68.02M Feb 26, 2021
FY2019 Dec 31, 2017 $87.14M Feb 28, 2020
FY2018 Dec 31, 2016 $73.62M Feb 28, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $222.79M Feb 25, 2026
FY2025 Dec 31, 2024 $299.47M Feb 25, 2026
FY2025 Dec 31, 2023 $143.74M Feb 25, 2026
FY2024 Dec 31, 2022 $181.82M Feb 27, 2025
FY2023 Dec 31, 2021 $192.49M Feb 27, 2024
FY2022 Dec 31, 2020 $176.85M Feb 23, 2023
FY2021 Dec 31, 2019 $146.00M Feb 24, 2022
FY2020 Dec 31, 2018 $144.60M Feb 26, 2021
FY2019 Dec 31, 2017 $130.95M Feb 28, 2020
FY2018 Dec 31, 2016 $114.39M Feb 28, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2019 Dec 31, 2019 $17.35M Feb 28, 2020
FY2019 Dec 31, 2018 $1.45M Feb 28, 2020
FY2019 Dec 31, 2017 $3.12M Feb 28, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.35B Feb 25, 2026
FY2025 Dec 31, 2024 $6.96B Feb 25, 2026
FY2024 Dec 31, 2023 $8.10B Feb 27, 2025
FY2023 Dec 31, 2022 $3.96B Feb 27, 2024
FY2022 Dec 31, 2021 $4.18B Feb 23, 2023
FY2021 Dec 31, 2020 $3.97B Feb 24, 2022
FY2020 Dec 31, 2019 $3.70B Feb 26, 2021
FY2019 Dec 31, 2018 $3.31B Feb 28, 2020
FY2018 Dec 31, 2017 $3.04B Feb 28, 2019
FY2017 Dec 31, 2016 $2.89B Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.68B Feb 25, 2026
FY2025 Dec 31, 2024 $4.77B Feb 25, 2026
FY2024 Dec 31, 2023 $5.46B Feb 27, 2025
FY2023 Dec 31, 2022 $2.51B Feb 27, 2024
FY2022 Dec 31, 2021 $2.56B Feb 23, 2023
FY2021 Dec 31, 2020 $2.41B Feb 24, 2022
FY2020 Dec 31, 2019 $1.99B Feb 26, 2021
FY2019 Dec 31, 2018 $1.88B Feb 28, 2020
FY2018 Dec 31, 2017 $1.62B Feb 28, 2019
FY2017 Dec 31, 2016 $1.54B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.66B Feb 25, 2026
FY2025 Dec 31, 2024 $2.19B Feb 25, 2026
FY2024 Dec 31, 2023 $2.64B Feb 27, 2025
FY2023 Dec 31, 2022 $1.44B Feb 27, 2024
FY2022 Dec 31, 2021 $1.62B Feb 23, 2023
FY2021 Dec 31, 2020 $1.53B Feb 24, 2022
FY2020 Dec 31, 2019 $1.70B Feb 26, 2021
FY2019 Dec 31, 2018 $1.43B Feb 28, 2020
FY2018 Dec 31, 2017 $1.41B Feb 28, 2019
FY2017 Dec 31, 2016 $1.35B Feb 28, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $45.90M Feb 25, 2026
FY2025 Dec 31, 2024 $51.37M Feb 25, 2026
FY2024 Dec 31, 2023 $46.98M Feb 27, 2025
FY2023 Dec 31, 2022 $21.36M Feb 27, 2024

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.61B) Feb 25, 2026
FY2025 Dec 31, 2024 ($2.15B) Feb 25, 2026
FY2024 Dec 31, 2023 ($1.70B) Feb 27, 2025
FY2023 Dec 31, 2022 ($1.25B) Feb 27, 2024
FY2022 Dec 31, 2021 ($1.07B) Feb 23, 2023
FY2021 Dec 31, 2020 ($896.55M) Feb 24, 2022
FY2020 Dec 31, 2019 ($733.25M) Feb 26, 2021
FY2019 Dec 31, 2018 ($615.45M) Feb 28, 2020
FY2018 Dec 31, 2017 ($468.40M) Feb 28, 2019
FY2017 Dec 31, 2016 ($346.06M) Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $180.11M Feb 25, 2026
FY2025 Dec 31, 2024 $159.70M Feb 25, 2026
FY2025 Dec 31, 2023 $121.57M Feb 25, 2026
FY2024 Dec 31, 2022 $103.34M Feb 27, 2025
FY2023 Dec 31, 2021 $89.67M Feb 27, 2024
FY2022 Dec 31, 2020 $124.25M Feb 23, 2023
FY2021 Dec 31, 2019 $270.30M Feb 24, 2022
FY2020 Dec 31, 2018 $100.32M Feb 26, 2021
FY2019 Dec 31, 2017 $102.43M Feb 28, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $0 Feb 28, 2018
FY2017 Dec 31, 2016 $55.38M Feb 28, 2018
FY2016 Dec 31, 2015 $0 Feb 28, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (1) Feb 25, 2026
FY2025 Dec 31, 2024 0 Feb 25, 2026
FY2025 Dec 31, 2023 (1) Feb 25, 2026
FY2024 Dec 31, 2022 0 Feb 27, 2025
FY2023 Dec 31, 2021 0 Feb 27, 2024
FY2022 Dec 31, 2020 0 Feb 23, 2023
FY2021 Dec 31, 2019 0 Feb 24, 2022
FY2020 Dec 31, 2018 0 Feb 26, 2021
FY2019 Dec 31, 2017 0 Feb 28, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (1) Feb 25, 2026
FY2025 Dec 31, 2024 0 Feb 25, 2026
FY2025 Dec 31, 2023 (1) Feb 25, 2026
FY2024 Dec 31, 2022 0 Feb 27, 2025
FY2023 Dec 31, 2021 0 Feb 27, 2024
FY2022 Dec 31, 2020 0 Feb 23, 2023
FY2021 Dec 31, 2019 0 Feb 24, 2022
FY2020 Dec 31, 2018 0 Feb 26, 2021
FY2019 Dec 31, 2017 0 Feb 28, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 216.02M Feb 25, 2026
FY2025 Dec 31, 2024 231.05M Feb 25, 2026
FY2024 Dec 31, 2023 230.89M Feb 27, 2025
FY2023 Dec 31, 2022 104.14M Feb 27, 2024
FY2022 Dec 31, 2021 103.90M Feb 23, 2023
FY2021 Dec 31, 2020 89.61M Feb 24, 2022
FY2020 Dec 31, 2019 89.46M Feb 26, 2021
FY2019 Dec 31, 2018 76.08M Feb 28, 2020
FY2018 Dec 31, 2017 67.29M Feb 28, 2019
FY2017 Mar 1, 2017 66.30M Feb 28, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $192.06M Feb 25, 2026
FY2025 Dec 31, 2024 $272.44M Feb 25, 2026
FY2025 Dec 31, 2023 $206.99M Feb 25, 2026
FY2024 Dec 31, 2022 $166.84M Feb 27, 2025
FY2023 Dec 31, 2021 $156.22M Feb 27, 2024
FY2022 Dec 31, 2020 $155.06M Feb 23, 2023
FY2021 Dec 31, 2019 $150.78M Feb 24, 2022
FY2020 Dec 31, 2018 $147.44M Feb 26, 2021
FY2019 Dec 31, 2017 $142.74M Feb 28, 2020
FY2018 Dec 31, 2016 $120.39M Feb 28, 2019